HematologyNews.net

Hematology Xagena

Xagena Mappa
Xagena Newsletter
OncologiaMedica.net
Medical Meeting

Search results for "Indolent lymphoma"

A new study has found for the first time that maintenance therapy with the novel antibody, Rituximab ( MabThera, Rituxan ) following Cyclophosphamide, Vincristine and Prednisone ( CVP ) therapy improv ...


Rituximab ( MabThera, Rituxan ) plus chemotherapy, most often CHOP ( Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone ), is the first-line standard of care for patients with advanced indolen ...